Paper9743293
Induction of p53-dependent and p53-independent cellular responses by topoisomerase 1 inhibitors.
McDonald AC and 1 other. Br J Cancer, 1998. Cited by 61 papers, by iCite.
Cite this record
ConductScience Library. Induction of p53-dependent and p53-independent cellular responses by topoisomerase 1 inhibitors. Papers, record 9743293. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/9743293
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Induction of p53-dependent and p53-independent cellular responses by topoisomerase 1 inhibitors.
- PubMed
Topics17
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antineoplastic Agents, Phytogenic | Major topic |
| Camptothecin | Major topic |
| Genes, p53 | Major topic |
| Ovarian Neoplasms | Major topic |
| Topotecan | Major topic |
| Apoptosis | |
| Cell Cycle | |
| DNA Topoisomerases, Type I | |
| Drug Resistance, Neoplasm | |
| Female | |
| Flow Cytometry | |
| Humans | |
| Irinotecan | |
| Topoisomerase I Inhibitors | |
| Tumor Cells, Cultured | |
| Tumor Stem Cell Assay | |
| Tumor Suppressor Protein p53 |
Source PubMed
References37
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 8426740 | Induction of nuclear accumulation of the tumor-suppressor protein p53 by DNA-damaging agents. | Oncogene | 1993 | https://conductscience.org/library/papers/8426740 | PubMed |
| 2 | 9288734 | Cell-cycle arrest versus cell death in cancer therapy. | Nat Med | 1997 | https://conductscience.org/library/papers/9288734 | PubMed |
| 3 | 8319228 | The cell cycle related differences in susceptibility of HL-60 cells to apoptosis induced by various antitumor agents. | Cancer Res | 1993 | https://conductscience.org/library/papers/8319228 | PubMed |
| 4 | 8364909 | Loss of a p53-associated G1 checkpoint does not decrease cell survival following DNA damage. | Cancer Res | 1993 | https://conductscience.org/library/papers/8364909 | PubMed |
| 5 | 8402660 | Role of the p53 tumor suppressor gene in cell cycle arrest and radiosensitivity of Burkitt's lymphoma cell lines. | Cancer Res | 1993 | https://conductscience.org/library/papers/8402660 | PubMed |
| 6 | 8406999 | Increased accumulation of p53 protein in cisplatin-resistant ovarian cell lines. | Int J Cancer | 1993 | https://conductscience.org/library/papers/8406999 | PubMed |
| 7 | 8106143 | Cross-resistance to diverse drugs is associated with primary cisplatin resistance in ovarian cancer cell lines. | Cancer Res | 1993 | https://conductscience.org/library/papers/8106143 | PubMed |
| 8 | 7505830 | Dose-intense taxol: high response rate in patients with platinum-resistant recurrent ovarian cancer. | J Natl Cancer Inst | 1994 | https://conductscience.org/library/papers/7505830 | PubMed |
| 9 | 8114714 | DNA strand breaks: the DNA template alterations that trigger p53-dependent DNA damage response pathways. | Mol Cell Biol | 1994 | https://conductscience.org/library/papers/8114714 | PubMed |
| 10 | 8137244 | Camptothecins: from bench research to hospital wards. | Cancer Res | 1994 | https://conductscience.org/library/papers/8137244 | PubMed |
| 11 | 8033090 | Cell cycle arrests and radiosensitivity of human tumor cell lines: dependence on wild-type p53 for radiosensitivity. | Cancer Res | 1994 | https://conductscience.org/library/papers/8033090 | PubMed |
| 12 | 7954409 | p53 gene mutations are associated with decreased sensitivity of human lymphoma cells to DNA damaging agents. | Cancer Res | 1994 | https://conductscience.org/library/papers/7954409 | PubMed |
| 13 | 7529916 | Evidence for a second cell cycle block at G2/M by p53. | Oncogene | 1995 | https://conductscience.org/library/papers/7529916 | PubMed |
| 14 | 7667317 | p53 controls both the G2/M and the G1 cell cycle checkpoints and mediates reversible growth arrest in human fibroblasts. | Proc Natl Acad Sci U S A | 1995 | https://conductscience.org/library/papers/7667317 | PubMed |
| 15 | 7669555 | The genetic analysis of ovarian cancer. | Br J Cancer | 1995 | https://conductscience.org/library/papers/7669555 | PubMed |
| 16 | 7577037 | CPT-11 (irinotecan) in the treatment of colorectal cancer. | Eur J Cancer | 1995 | https://conductscience.org/library/papers/7577037 | PubMed |
| 17 | 8564846 | Loss of normal p53 function confers sensitization to Taxol by increasing G2/M arrest and apoptosis. | Nat Med | 1996 | https://conductscience.org/library/papers/8564846 | PubMed |
| 18 | 8564971 | Association between cisplatin resistance and mutation of p53 gene and reduced bax expression in ovarian carcinoma cell systems. | Cancer Res | 1996 | https://conductscience.org/library/papers/8564971 | PubMed |
| 19 | 8640828 | Microsatellite instability, apoptosis, and loss of p53 function in drug-resistant tumor cells. | Cancer Res | 1996 | https://conductscience.org/library/papers/8640828 | PubMed |
| 20 | 8654922 | p53: puzzle and paradigm. | Genes Dev | 1996 | https://conductscience.org/library/papers/8654922 | PubMed |
Cited by22
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 61 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 35008354 | Targeted Disruption of E6/p53 Binding Exerts Broad Activity and Synergism with Paclitaxel and Topotecan against HPV-Transformed Cancer Cells. | Cancers (Basel) | 2021 | https://conductscience.org/library/papers/35008354 | PubMed |
| 28453558 | Tumor-targeted SN38 inhibits growth of early stage non-small cell lung cancer (NSCLC) in a KRas/p53 transgenic mouse model. | PLoS One | 2017 | https://conductscience.org/library/papers/28453558 | PubMed |
| 27267850 | A Novel HSP90 Inhibitor-Drug Conjugate to SN38 Is Highly Effective in Small Cell Lung Cancer. | Clin Cancer Res | 2016 | https://conductscience.org/library/papers/27267850 | PubMed |
| 26657503 | Inhibition of hypoxia inducible factor 1 and topoisomerase with acriflavine sensitizes perihilar cholangiocarcinomas to photodynamic therapy. | Oncotarget | 2016 | https://conductscience.org/library/papers/26657503 | PubMed |
| 24829906 | The molecular mechanisms of Tanshinone IIA on the apoptosis and arrest of human esophageal carcinoma cells. | Biomed Res Int | 2014 | https://conductscience.org/library/papers/24829906 | PubMed |
| 23537372 | UCN-01 induces S and G2/M cell cycle arrest through the p53/p21(waf1) or CHK2/CDC25C pathways and can suppress invasion in human hepatoma cell lines. | BMC Cancer | 2013 | https://conductscience.org/library/papers/23537372 | PubMed |
| 23469123 | Altered processing of amyloid precursor protein in cells undergoing apoptosis. | PLoS One | 2013 | https://conductscience.org/library/papers/23469123 | PubMed |
| 23180349 | Lack of Bax expression is associated with irinotecan-based treatment activity in advanced colorectal cancer patients. | Clin Transl Oncol | 2013 | https://conductscience.org/library/papers/23180349 | PubMed |
| 21372224 | Humanized anti-Trop-2 IgG-SN-38 conjugate for effective treatment of diverse epithelial cancers: preclinical studies in human cancer xenograft models and monkeys. | Clin Cancer Res | 2011 | https://conductscience.org/library/papers/21372224 | PubMed |
| 20504876 | Defective p53 antiangiogenic signaling in glioblastoma. | Neuro Oncol | 2010 | https://conductscience.org/library/papers/20504876 | PubMed |
| 20196838 | Pregnane X Receptor (PXR) expression in colorectal cancer cells restricts irinotecan chemosensitivity through enhanced SN-38 glucuronidation. | Mol Cancer | 2010 | https://conductscience.org/library/papers/20196838 | PubMed |
| 19727814 | P53 and p38 MAPK pathways are involved in MONCPT-induced cell cycle G2/M arrest in human non-small cell lung cancer A549. | J Cancer Res Clin Oncol | 2010 | https://conductscience.org/library/papers/19727814 | PubMed |
| 19445707 | Increased susceptibility of spinal muscular atrophy fibroblasts to camptothecin is p53-independent. | BMC Cell Biol | 2009 | https://conductscience.org/library/papers/19445707 | PubMed |
| 17164761 | Schedule-dependent activity of 5-fluorouracil and irinotecan combination in the treatment of human colorectal cancer: in vitro evidence and a phase I dose-escalating clinical trial. | Br J Cancer | 2007 | https://conductscience.org/library/papers/17164761 | PubMed |
| 16280599 | High salt culture conditions suppress proliferation of rat C6 glioma cell by arresting cell-cycle progression at S-phase. | J Mol Neurosci | 2005 | https://conductscience.org/library/papers/16280599 | PubMed |
| 12032863 | Enhanced tumor killing by Apo2L/TRAIL and CPT-11 co-treatment is associated with p21 cleavage and differential regulation of Apo2L/TRAIL ligand and its receptors. | Oncogene | 2002 | https://conductscience.org/library/papers/12032863 | PubMed |
| 11986787 | Effect of non-steroidal anti-inflammatory drugs on colon carcinoma Caco-2 cell responsiveness to topoisomerase inhibitor drugs. | Br J Cancer | 2002 | https://conductscience.org/library/papers/11986787 | PubMed |
| 11961671 | Intraperitoneal adenovirus-mediated suicide gene therapy in combination with either topotecan or paclitaxel in nude mice with human ovarian cancer. | Cancer Gene Ther | 2002 | https://conductscience.org/library/papers/11961671 | PubMed |
| 11313813 | Replication and cytolysis of an E1B-attenuated adenovirus in drug-resistant ovarian tumour cells is associated with reduced apoptosis. | Gene Ther | 2001 | https://conductscience.org/library/papers/11313813 | PubMed |
| 10980131 | Expression of p57(KIP2) potently blocks the growth of human astrocytomas and induces cell senescence. | Am J Pathol | 2000 | https://conductscience.org/library/papers/10980131 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| TP53 | 7157 | PubTator's text mining | https://conductscience.org/library/genes/7157 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/9743293
GET https://conductscience.org/api/papers/v1/9743293/references?page=2